CCL2 and hepatocellular carcinoma: Furthermore, the upregulation of this gene, as well as CCL2, IL6, and LOXL2, has been implicated as part of the effects of cancer-associated fibroblasts in promoting progression of hepatocellular carcinoma cells (Lin et al., 2012).